Headquartered in France, Polyplus-transfection (Polyplus) was founded in 2001 as a spin-off from the Genetic Chemistry Laboratory in the Faculty of Pharmacy, University of Strasbourg. Polyplus is the leading biotechnology company that supports gene and cell therapy, biologics manufacturing and life science research with innovative nucleic acid transfection solutions. Its strengths include over 20 years of experience in manufacturing transfection solutions and offering tailored scientific and regulatory support to clients to accelerate their research. Polyplus has focused its research on chemical transfection vectors as opposed to electroporation that can subject cells to significant stress.